Glossary
|
AIMS |
Arthritis Impact Measurement Scale |
|
APR |
Acute Phase Reactant |
|
CCP |
Cyclic Citrullinated Peptide |
|
CRP |
C-Reactive Protein |
|
DAS28 |
Disease Activity Score based on 28 joints |
|
DMARD |
Disease Modifying Anti-Rheumatic Drug |
|
ESR |
Erythrocyte Sedimentation Rate (ESR) |
|
HAQ |
Health Assessment Questionnaire |
|
IR |
Inadequate Response |
|
MCP |
Metacarpophalangeal |
|
MTP |
Metatarsophalangeal |
|
PPD |
Purified Protein Derivative |
|
RA |
Rheumatoid Arthritis |
|
RF |
Rheumatoid Factor |
|
SDAI |
Simplified Disease Activity Index |
|
SJC |
Swollen Joint Count |
|
TJC |
Tender Joint Count |
|
VAS |
Visual Analogue Scale |
|
||||||||||||||||||||||||||
|
|
- © 2008 F. Hoffmann-La Roche Ltd. The site is intended for non US physicians and scientific media only.Prescribing information, pricing and indications for MabThera may differ from country to country.Please consult your local Roche company for such information you may be interested in.